Form 4: Nuvation Bio Executive Moses Makunje Reports Stock Option Grant and Share Acquisitions

Moses Makunje, VP of Finance at Nuvation Bio, reports the acquisition of stock options and shares, including those from the Employee Stock Purchase Plan.

Summary

• Moses Makunje, a VP at Nuvation Bio, filed a Form 4 detailing changes in beneficial ownership.
• On February 28, 2025, Makunje was granted stock options to purchase 250,000 shares of Class A Common Stock at an exercise price of $1.97.
• These options vest 25% on the one-year anniversary of the grant date and then monthly over the subsequent 36 months, contingent upon continuous service.
• Makunje also reported owning 15,275 shares of Class A Common Stock.
• This includes 3,000 shares acquired on May 17, 2024, and 1,663 shares acquired on November 19, 2024, through the company's Employee Stock Purchase Plan.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard regulatory filing detailing stock option grants and ESPP purchases, which are common compensation practices.

Positives

• The stock option grant aligns Makunje's interests with those of the shareholders, incentivizing him to contribute to the company's success.
• Participation in the Employee Stock Purchase Plan demonstrates confidence in the company's future.

Future Outlook

The vesting schedule of the stock options indicates a long-term commitment from the executive to the company.

Industry Context

Form 4 filings are a routine part of regulatory compliance for publicly traded companies, providing transparency into insider transactions. This filing indicates standard compensation practices.

Comparison to Industry Standards

• Stock option grants are a common form of executive compensation in the biotechnology industry, used to align management's interests with shareholder value.
• Vesting schedules, such as the one described (25% after one year, then monthly over 36 months), are typical for stock option grants.
• Comparing the size of the grant (250,000 shares) to similar companies would require analyzing their executive compensation packages.

Stakeholder Impact

• The stock option grant could potentially increase shareholder value if the executive's performance leads to company growth.
• Employees participating in the Employee Stock Purchase Plan benefit from the opportunity to purchase company stock at potentially discounted prices.

Key Dates